These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 20520538)

  • 21. Novel therapies blocking the renin-angiotensin-aldosterone system in the management of hypertension and related disorders.
    Krum H; Gilbert RE
    J Hypertens; 2007 Jan; 25(1):25-35. PubMed ID: 17143168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hypertension in patients with diabetes].
    Poulsen PL; Hansen KW; Gaede PH; Rossing P
    Ugeskr Laeger; 2009 Jun; 171(24):2031-4. PubMed ID: 19523370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The future of renin inhibition].
    Uresin AY; Baran E
    Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():32-8. PubMed ID: 20019475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antihypertensive drug therapy--combination of AT1-receptor blocker and betablocker].
    Schindler C; Kosa M; Schröder J; Kirch W
    Dtsch Med Wochenschr; 2010 May; 135(3):98. PubMed ID: 20077385
    [No Abstract]   [Full Text] [Related]  

  • 25. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renin inhibition: what are the clinical perspectives?
    Hollenberg NK
    Semin Nephrol; 2007 Sep; 27(5):511-8. PubMed ID: 17868787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The renin system: is direct renin inhibition different from blockade at the AT1 receptor or the ACE step?
    Hollenberg NK
    Rev Cardiovasc Med; 2007; 8 Suppl 2():S7-13. PubMed ID: 17401314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progression of renal disease: renoprotective specificity of renin-angiotensin system blockade.
    Griffin KA; Bidani AK
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):1054-65. PubMed ID: 17699327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hypertension therapies compared. Are the new nevertheless better than the old?].
    MMW Fortschr Med; 2005 Mar; 147(12):6, 8. PubMed ID: 15832780
    [No Abstract]   [Full Text] [Related]  

  • 30. Drug therapy of hypertension: efficacy and cost.
    Langford HG
    J La State Med Soc; 1975 Dec; 127(12):465-9. PubMed ID: 1214096
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacogenetics of antihypertensive treatment.
    Arnett DK; Claas SA; Glasser SP
    Vascul Pharmacol; 2006 Feb; 44(2):107-18. PubMed ID: 16356784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hypertension 2007-2008].
    Chatzikyrkou C; Menne J; Haller H
    Med Klin (Munich); 2009 Aug; 104(8):614-21. PubMed ID: 19701732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blood pressure drugs compared. ACE inhibitors beat ARBs hands-down for survival benefit.
    Harv Heart Lett; 2012 Jun; 22(10):5. PubMed ID: 22764400
    [No Abstract]   [Full Text] [Related]  

  • 34. A rational approach to hypertension treatment in the older patient.
    Flack JM; Woolley A; Esunge P; Grimm RH
    Geriatrics; 1992 Nov; 47(11):24-8, 33-8. PubMed ID: 1358761
    [No Abstract]   [Full Text] [Related]  

  • 35. Dietary salt intake and hypertension.
    Cappuccio FP; Markandu ND; MacGregor GA
    Klin Wochenschr; 1991; 69 Suppl 25():17-25. PubMed ID: 1921246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Kjeldsen SE; Julius S
    Am Heart J; 2004 Nov; 148(5):747-54. PubMed ID: 15523303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cochrane for clinicians. First-line treatment for hypertension.
    Bui Q
    Am Fam Physician; 2010 Jun; 81(11):1333-5. PubMed ID: 20521752
    [No Abstract]   [Full Text] [Related]  

  • 38. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
    Lebel M; Rodrigue ME; Agharazii M; Larivière R
    Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resistant hypertension: an overview of evaluation and treatment.
    Sarafidis PA; Bakris GL
    J Am Coll Cardiol; 2008 Nov; 52(22):1749-57. PubMed ID: 19022154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aliskiren: a new inhibitor of renin-angiotensin aldosterone system activity.
    Dalla Vestra M; Simioni N; Masiero A
    Minerva Endocrinol; 2009 Dec; 34(4):333-8. PubMed ID: 20046162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.